查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球生命科学分析市场：按类型、服务、应用、最终用户和地区 - 预测（至 2029 年）
市场调查报告书
商品编码
1565793

全球生命科学分析市场：按类型、服务、应用、最终用户和地区 - 预测（至 2029 年）

Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & marketing, Drug Safety), End User (Pharma, Medical Device), & Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 386 Pages | 订单完成后即时交付

价格

全球生命科学分析市场规模预计将从 2024 年的 356.9 亿美元增加到 2029 年的 619.4 亿美元，预测期内复合年增长率为 11.7%。

该市场是由生命科学巨量资料的异质性和复杂性以及在跨行业各种应用中利用先进技术的分析解决方案驱动的，包括研发、商业化（例如开发、定价、销售和营销）和安全预计成长是由于需求突然增加。此外，由于需要提高生命科学和医疗行业的资料标准化，该市场正在呈现成长。然而，新兴经济体IT基础设施不足以及不愿采用分析解决方案预计将对市场成长构成挑战。

调查范围
调查年份 2022-2029
基准年 2023年
预测期 2024-2029
单元 百万/十亿美元
部分 按类型、组件、应用、最终用户
目标区域 北美、欧洲、亚太地区、拉丁美洲、中东/非洲

“生命科学分析软体细分市场下的软体即服务 (SaaS)子区隔预计将在预测期内实现最高增长。”

SaaS 细分市场的成长是由来自各种云端孤岛的资料的无缝整合、远端位置的无限制用户存取、低维护成本、高安全性、隐私性、易于存取以及无需前期投资硬体等诸多因素推动的。此外，SaaS 模型提供的多种应用程式涵盖会计、效能监控以及透过网路邮件和即时通讯工具进行通讯等领域，进一步促进了该细分市场的成长。

“从最终用户来看，製药和生物技术公司预计将在预测期内主导市场。”

2023年，从最终用户来看，製药和生技公司占据了很大的市场。预计该细分市场在预测期内也将实现最高成长。由于製药和生物技术公司的研发费用不断增加，分析在药品的研发过程、销售和行销中的使用越来越多，以及分析在药物安全检测的资料并呈现出高成长。此外，个人化医疗和精准治疗的推动以及人工智慧和机器学习的整合正在进一步增加製药和生物技术行业中的分析价值。

“预计亚太地区将在预测期内实现最高的市场成长。”

该地区的高成长是由该地区庞大且不断增长的患者人口、对创新治疗的需求不断增长、医疗保健巨量资料的出现、HCIT 基础设施支出的增加以及该地区对新兴国家不断增长的需求推动的。政府努力加快在整个生命科学产业采用数位化解决方案，并大力关注跨工作流程整合先进技术，这也对成长做出了贡献。

本报告研究和分析了全球生命科学分析市场，提供了关键驱动因素和限制因素、竞争格局和未来趋势的资讯。

目录

第一章简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

  • 生命科学分析市场概述
  • 生命科学分析市场：按地区
  • 北美生命科学分析市场：依最终用户、按地区划分
  • 生命科学分析市场：地理简介
  • 生命科学分析市场：已开发市场 vx。

第五章市场概况

  • 介绍
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 产业趋势
    • 在商业业务中越来越多地采用分析
    • 使用资料和分析加速药物发现和开发
    • 专注于即时资料分析
  • 技术分析
    • 主要技术
    • 互补技术
    • 邻近技术
  • 生态系分析
  • 价值链分析
  • 波特五力分析
  • 主要相关利益者和采购标准
  • 案例研究分析
  • 监管环境
    • 监管机构、政府机构和其他组织
    • 北美洲
    • 欧洲
    • 亚太地区
    • 中东/非洲
    • 拉丁美洲
  • 价格分析
    • 平均销售价格：主要企业，依用途
    • 平均售价：按地区
  • 重大会议和活动（2024-2025）
  • 影响客户业务的趋势/干扰
  • 专利分析
  • 最终用户分析
    • 未满足的需求
    • 最终用户的期望
  • 生命科学分析经营模式
    • 基于订阅的模式
    • SaaS模式
    • 计量收费/基于使用的模型
    • 企业许可
    • 免费增值模式
    • 企业许可
    • 并发许可
    • 咨询服务模式
    • 伙伴关係/收益共享模式
    • 混合模式
  • 投资金筹措场景
  • 人工智慧/生成人工智慧对生命科学分析市场的影响
    • 关键用例和市场潜力
    • 人工智慧/生成式人工智慧实施案例研究
    • 使用者准备和影响评估

第六章生命科学分析市场：依类型

  • 介绍
  • 说明分析
  • 预测分析
  • 指示性分析

第七章生命科学分析市场：依组成部分

  • 介绍
  • 服务
    • 託管服务
    • 专业服务
  • 软体
    • 本地解决方案
    • 云端基础的解决方案
    • 基于SaaS的解决方案

第 8 章生命科学分析市场：依应用分类

  • 介绍
  • 研究与开发
    • 临床试验
    • 临床前/药物发现
  • 商业分析
    • 销售和行销支持
    • 市场进入
    • RWE/价值证据
    • 参与服务
  • 监理合规性
  • 製造/供应链优化
  • 安全
    • 药物安全检测
    • 医疗设备安全
    • 诊断警惕

第 9 章生命科学分析市场：依最终使用者划分

  • 介绍
  • 製药和生物技术公司
  • 医疗设备公司
  • 研究中心
  • 委託生命科学组织

第 10 章生命科学分析市场：按地区

  • 介绍
  • 北美洲
    • 北美宏观经济展望
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲宏观经济展望
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 亚太宏观经济展望
    • 日本
    • 中国
    • 印度
    • 其他亚太地区
  • 拉丁美洲
    • 拉丁美洲宏观经济展望
    • 巴西
    • 墨西哥
    • 其他拉丁美洲
  • 中东/非洲
    • 中东和非洲宏观经济前景
    • 海湾合作委员会国家
    • 其他中东/非洲

第十一章竞争格局

  • 概述
  • 主要企业策略/主要企业
  • 收益分析
  • 市场占有率分析
  • 企业评价矩阵：主要企业（2023年）
  • 公司评估矩阵：Start-Ups/中小企业（2023）
  • 品牌/软体比较分析
  • 评价及财务指标
  • 竞争场景

第十二章 公司简介

  • 主要企业
    • ORACLE
    • MERATIVE
    • SAS INSTITUTE INC.
    • ACCENTURE
    • IQVIA INC.
    • COGNIZANT
    • WIPRO
    • VERADIGM LLC
    • OPTUM, INC.
    • MICROSOFT
    • MAXISIT
    • EXLSERVICE HOLDINGS, INC.
    • INOVALON
    • CITIUSTECH INC.
    • SAAMA
    • AXTRIA
    • CLARIVATE
    • THOUGHTSPHERE
    • THOUGHTSPOT INC.
    • SALESFORCE, INC.
  • 其他公司
    • GOOGLE LLC
    • AMAZON WEB SERVICES, INC.
    • VEEVA SYSTEMS
    • ELSEVIER
    • KOMODO HEALTH, INC.

第十三章附录

Product Code: HIT 4869

The global Life science analytics market is projected to reach USD 61.94 billion by 2029 from USD 35.69 billion in 2024, at a CAGR of 11.7% during the forecast period. The market is expected to grow as a result of the heterogenity & complexity of big data in life sciences, surging demand for technologically advanced analytical solutions for various applications across the industry, such as, research & development, commercialization (market access, pricing, sales & marketing, etc), safety, among others. Moreover, the market has experienced growth due to the need for improved data standardization across the life science & healthcare industry. However, insufficient IT infrastructure, and reluctance towards adoption of analytics solutions in emerging economies are some of the factors that are expected to pose a challenge to the market growth.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredMillion/Billion (USD)
SegmentsBy Type, Component, Application, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

"Software-as-a-service (SaaS) subsegment, under the life science analytics software segment is expected to register highest growth during the forecast period."

The life science analytics software segment is sub-segmented into on-premise, cloud-based, and software-as-a-service. In 2023, the software-as-a-service (SaaS) segment is expected to register the highest growth during the forecast period. The growth of the SaaS segment is attributed to the ample number of advantages offered by this model, such as the seamless integration of data from various cloud silos, unlimited user access from remote locations, low maintenance costs, high security, privacy, easy accessibility, no upfront capital investment for hardware, and extreme capacity flexibility and optimized resource utilization. Moreover, several applications offered by the SaaS model, spanning areas such as accounting, performance monitoring, and communication through webmail and instant messengers, further contribute to the segment's growth.

"Pharmaceutical & Biotechnology companies is projected to dominate the market in the life science analytics market, by end user during the forecast period."

The pharmaceutical & biotechnology companies, medical device companies, research institutes, and outsourced life science organizations such as CROS, CMOs, independent contractors, etc., make up the end user segments of the life science analytics market. In 2023, the pharmaceutical & biotechnology companies accounted for a significant share of the life science analytics market, by end user. The segment is also expected to register paramount growth during the forecast period. The prominent position & high growth of this segment is due to the increasing R&D expenditure of pharma & biotech companies, the increasing use of analytics for research & development processes, pharma sales and marketing, growing importance of analytics in pharmacovigilance, the need to accelerate drug discovery, optimize clinical trials, and enhance regulatory compliance through data-driven insights. Moreover, the push for personalized medicine and precision therapeutics, The integration of AI and machine learning further strengthens the value of analytics in the pharma & biotech industry.

"Asia Pacific is expected to register highest market growth during the forecast period."

The life science analytics market is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Asia Pacific region is expected to register highest growth during the forecast period. The high growth of this region is attributed to the the presence of a large and growing patient population in the region, the increasing need for innovative therapies, the emergence of big data in healthcare, increasing spending on HCIT infrastructure, and the shifting focus of various market players on emerging countries in the region. Government initiatives to promote the adoption of digital & technologically enabled solutions across life science industry, and significant focus on integrating sophisticated technologies across the workflows also contributes to the growth.

The break-down of primary participants is as mentioned below:

  • By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
  • By Designation - Directors: 30%, Manager: 34%, and Others: 36%
  • By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7% and Middle East & Africa: 5%

List of Companies Profiled in the Report

    • Oracle (US)
    • Merative (formerly IBM) (US)
    • SAS Institute (US)
    • Accenture (Ireland)
    • IQVIA (US)
    • Cognizant (US)
    • Wipro (India)
    • Veradigm (US)
    • Optum (US)
    • Microsoft (US)
    • MaxisIT (US)
    • ExlService Holdings (US)
    • Inovalon (US)
    • CitiusTech (US)
    • Saama (US)
    • Axtria (US)
    • Clarivate (UK)
    • ThoughtSphere (US)
    • ThoughtSpot (US)
    • Salesforce (US)
    • Google LLC (US)
    • Amazon Web Services, Inc. (US)
    • Veeva Systems (US)
    • Elsevier (Netherlands)
    • Komodo Health, Inc. (US)

Research Coverage:

The report analyzes the Life science analytics market and aims to estimate the market size and future growth potential of various market segments, based on type, component, applicarion, end user, and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total life science analytics market. The report forecasts the revenue of the market segments with respect to five major regions. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

  • Analysis of key drivers (rising pressure to curb healthcare spending, need for improved data standardization, technological advancements in analytical solutions, heterogeneity and complexity of big data in life sciences, growing adoption of analytical solutions in clinical trials, increasing R&D expenditure in pharmaceutical & biotechnology companies), restraints (high implementation costs of advanced analytical solutions, data privacy concerns), opportunities (growing focus on value-based care, use of analytics in precision & personalized medicine, big data analytics for R&D productivity, growing adoption of cloud-based analytics), challenges (issues associated with data integration, shortage of skilled personnel, reluctance to adopt life science analytics solutions in emerging countries) are factors contributing the growth of the life science analytics market.
  • Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the life science analytics market.
  • Market Development: Comprehensive information on the lucrative emerging markets, type of solution, component, deployment model, industry, and region.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the life science analytics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global life science analytics market such as Oracle (US), Merative (formerly IBM) (US), SAS Institute (US), Accenture (Ireland), IQVIA (US), Cognizant (US), Wipro (India), Veradigm (US), Optum (US).

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key industry insights
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 LIMITATIONS
    • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.6.2 SCOPE-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 LIFE SCIENCE ANALYTICS MARKET OVERVIEW
  • 4.2 LIFE SCIENCE ANALYTICS MARKET, BY REGION
  • 4.3 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER & REGION
  • 4.4 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHIC SNAPSHOT
  • 4.5 LIFE SCIENCE ANALYTICS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising pressure to curb healthcare spending
      • 5.2.1.2 Need for improved data standardization
      • 5.2.1.3 Technological advancements in analytical solutions
      • 5.2.1.4 Heterogeneity and complexity of big data in life sciences
      • 5.2.1.5 Growing adoption of analytical solutions in clinical trials
      • 5.2.1.6 Increasing R&D expenditure in pharmaceutical & biotechnology companies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High implementation costs of advanced analytical solutions
      • 5.2.2.2 Data privacy concerns
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing focus on value-based care
      • 5.2.3.2 Use of analytics in precision & personalized medicine
      • 5.2.3.3 Big data analytics for R&D productivity
      • 5.2.3.4 Growing adoption of cloud-based analytics
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Issues associated with data integration
      • 5.2.4.2 Shortage of skilled personnel
      • 5.2.4.3 Reluctance to adopt life science analytics solutions in emerging countries
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 GROWING ADOPTION OF ANALYTICS IN COMMERCIAL OPERATIONS
    • 5.3.2 LEVERAGING DATA & ANALYTICS TO ACCELERATE DRUG DISCOVERY & DEVELOPMENT
    • 5.3.3 FOCUS ON REAL-TIME DATA ANALYTICS
  • 5.4 TECHNOLOGY ANALYSIS
    • 5.4.1 KEY TECHNOLOGIES
      • 5.4.1.1 Artificial intelligence and machine learning
      • 5.4.1.2 Big data analytics
      • 5.4.1.3 Quantum computing
    • 5.4.2 COMPLEMENTARY TECHNOLOGIES
      • 5.4.2.1 Bioinformatics tools
      • 5.4.2.2 Internet of things
    • 5.4.3 ADJACENT TECHNOLOGIES
      • 5.4.3.1 Blockchain
  • 5.5 ECOSYSTEM ANALYSIS
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
    • 5.7.2 THREAT OF SUBSTITUTES
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
    • 5.7.4 BARGAINING POWER OF BUYERS
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.8 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.8.2 BUYING CRITERIA
  • 5.9 CASE STUDY ANALYSIS
    • 5.9.1 NOVARTIS USES MULTI-CLOUD DATA ANALYTICS PLATFORM TO OPTIMIZE OPERATIONS AND ACCELERATE INNOVATION
    • 5.9.2 SAS VISUAL ANALYTICS HELPS MAXIMIZE PROFITABILITY THROUGH PRESCRIPTIVE ANALYTICS & DATA VISUALIZATION
    • 5.9.3 STREAMLINING REGULATORY MONITORING AND IMPACT ASSESSMENTS: GEDEON RICHTER'S PARTNERSHIP WITH CLARIVATE
  • 5.10 REGULATORY LANDSCAPE
    • 5.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.10.2 NORTH AMERICA
    • 5.10.3 EUROPE
    • 5.10.4 ASIA PACIFIC
    • 5.10.5 MIDDLE EAST & AFRICA
    • 5.10.6 LATIN AMERICA
  • 5.11 PRICING ANALYSIS
    • 5.11.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY APPLICATION
    • 5.11.2 AVERAGE SELLING PRICE, BY REGION
  • 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 5.14 PATENT ANALYSIS
    • 5.14.1 PATENT PUBLICATION TRENDS
    • 5.14.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES
    • 5.14.3 MAJOR PATENTS
  • 5.15 END-USER ANALYSIS
    • 5.15.1 UNMET NEEDS
    • 5.15.2 END-USER EXPECTATIONS
  • 5.16 LIFE SCIENCE ANALYTICS BUSINESS MODELS
    • 5.16.1 SUBSCRIPTION-BASED MODEL
    • 5.16.2 SAAS MODEL
    • 5.16.3 PAY-PER-USE/USAGE-BASED MODEL
    • 5.16.4 ENTERPRISE LICENSING
    • 5.16.5 FREEMIUM MODEL
    • 5.16.6 ENTERPRISE LICENSING
    • 5.16.7 CONCURRENT LICENSING
    • 5.16.8 CONSULTING SERVICES MODEL
    • 5.16.9 PARTNERSHIP/REVENUE-SHARING MODEL
    • 5.16.10 HYBRID MODELS
  • 5.17 INVESTMENT & FUNDING SCENARIO
  • 5.18 IMPACT OF AI/GENERATIVE AI ON LIFE SCIENCE ANALYTICS MARKET
    • 5.18.1 TOP USE CASES & MARKET POTENTIAL
      • 5.18.1.1 Key use cases
    • 5.18.2 CASE STUDIES OF AI/GENERATIVE AI IMPLEMENTATION
      • 5.18.2.1 Case Study 1: Knowledge Mining for a Global Biopharmaceutical Company
      • 5.18.2.2 Healthcare analytics market
    • 5.18.3 USER READINESS AND IMPACT ASSESSMENT
      • 5.18.3.1 User readiness
        • 5.18.3.1.1 Pharmaceutical & biotechnology companies
        • 5.18.3.1.2 Medical device companies
        • 5.18.3.1.3 Research centers
        • 5.18.3.1.4 Outsourced life science organizations
      • 5.18.3.2 Impact assessment
        • 5.18.3.2.1 User A: Pharmaceutical & biotechnology companies
          • 5.18.3.2.1.1 Implementation
          • 5.18.3.2.1.2 Impact
        • 5.18.3.2.2 User B: Medical device companies
          • 5.18.3.2.2.1 Implementation
          • 5.18.3.2.2.2 Impact
        • 5.18.3.2.3 User C: Research institutes
          • 5.18.3.2.3.1 Implementation
          • 5.18.3.2.3.2 Impact
        • 5.18.3.2.4 User D: Outsourced life science organizations
          • 5.18.3.2.4.1 Implementation
          • 5.18.3.2.4.2 Impact

6 LIFE SCIENCE ANALYTICS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 DESCRIPTIVE ANALYTICS
    • 6.2.1 ADVANCED VISUAL DATA EXPLORATION AND SUPPORT FOR INNOVATION TO DRIVE DEMAND
  • 6.3 PREDICTIVE ANALYTICS
    • 6.3.1 SIMULATION DEVELOPMENT FOR PREDICTING FUTURE TRENDS TO PROPEL MARKET GROWTH
  • 6.4 PRESCRIPTIVE ANALYTICS
    • 6.4.1 REAL-TIME ANALYSIS FOR IMPROVED DECISION-MAKING TO SUPPORT MARKET GROWTH

7 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT

  • 7.1 INTRODUCTION
  • 7.2 SERVICES
    • 7.2.1 MANAGED SERVICES
      • 7.2.1.1 Analytical services
        • 7.2.1.1.1 Focus on expediting approvals and product launches to drive growth
      • 7.2.1.2 Consulting services
        • 7.2.1.2.1 Support for R&D, process development, and other workflow processes to drive market
    • 7.2.2 PROFESSIONAL SERVICES
      • 7.2.2.1 Training & implementation
        • 7.2.2.1.1 Stringent regulations, increasing competition, and need for skill development to propel demand
      • 7.2.2.2 Maintenance & support services
        • 7.2.2.2.1 Rising complexity of analytical technologies and expanding research needs to support market growth
      • 7.2.2.3 Other professional services
  • 7.3 SOFTWARE
    • 7.3.1 ON-PREMISE SOLUTIONS
      • 7.3.1.1 Provision of multivendor architecture and security benefits to drive market
    • 7.3.2 CLOUD-BASED SOLUTIONS
      • 7.3.2.1 Real-time analysis and elimination of purchasing costs for software & hardware to drive adoption
    • 7.3.3 SAAS-BASED SOLUTIONS
      • 7.3.3.1 Increasing adoption of digital solutions and advantages of cloud-based models to drive growth

8 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 RESEARCH & DEVELOPMENT
    • 8.2.1 CLINICAL TRIALS
      • 8.2.1.1 Life science analytics market for clinical trials, by type
        • 8.2.1.1.1 Laboratory services
          • 8.2.1.1.1.1 Better accuracy, efficiency, and data interpretation to support demand for lab services
        • 8.2.1.1.2 Patient recruitment services
          • 8.2.1.1.2.1 Need for better candidate identification and enrollment forecasting to propel market growth
        • 8.2.1.1.3 Site identification services
          • 8.2.1.1.3.1 Benefits in locating ideal trial sites and interpreting data to support adoption
        • 8.2.1.1.4 Other clinical trial services
      • 8.2.1.2 Life science analytics market for clinical trials, by phase
        • 8.2.1.2.1 PHASE I
          • 8.2.1.2.1.1 Strong pipeline of pharmaceutical companies to propel market growth
        • 8.2.1.2.2 PHASE II
          • 8.2.1.2.2.1 Extended duration of phase II studies to create growth opportunities for CROs
        • 8.2.1.2.3 PHASE III
          • 8.2.1.2.3.1 Rising trial expenditure to drive demand for cost-effective clinical research services
    • 8.2.2 PRECLINICAL & DRUG DISCOVERY
      • 8.2.2.1 Ability to assist researchers in process innovation and decision support to drive adoption
  • 8.3 COMMERCIAL ANALYTICS
    • 8.3.1 SALES & MARKETING SUPPORT
      • 8.3.1.1 Rising analysis of digital marketing effectiveness to drive adoption
    • 8.3.2 MARKET ACCESS
      • 8.3.2.1 Focus on strategic pricing, reimbursement, and policy changes to support market growth
    • 8.3.3 RWE & VALUE EVIDENCE
      • 8.3.3.1 Increased data integration, partnerships, and technological to propel use of RWE
    • 8.3.4 ENGAGEMENT SERVICES
      • 8.3.4.1 Need for better patient engagement, digital advancements, and AI integration to propel market
  • 8.4 REGULATORY COMPLIANCE
    • 8.4.1 STRINGENT REQUIREMENTS FOR COMPLIANCE ADHERENCE TO DRIVE ADOPTION
  • 8.5 MANUFACTURING & SUPPLY CHAIN OPTIMIZATION
    • 8.5.1 RISING NEED FOR REDUCING LOGISTICS COSTS TO SUPPORT MARKET GROWTH
  • 8.6 SAFETY
    • 8.6.1 PHARMACOVIGILANCE
      • 8.6.1.1 Monitoring of drug trials and medication programs to fuel market uptake
    • 8.6.2 MEDICAL DEVICE SAFETY
      • 8.6.2.1 Stringent safety standards, rigorous risk assessments, and robust quality control to drive demand
    • 8.6.3 DIAGNOSTIC VIGILANCE
      • 8.6.3.1 Continuous monitoring, integration of diverse data sources, and ongoing education to enhance accuracy and thoroughness

9 LIFE SCIENCE ANALYTICS MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 9.2.1 RISING NEED FOR INNOVATIVE THERAPIES TO DRIVE ANALYTICS USAGE IN PRODUCT DEVELOPMENT
  • 9.3 MEDICAL DEVICE COMPANIES
    • 9.3.1 ADOPTION OF DATA ANALYTICS FOR DEVICE COMMERCIALIZATION TO DRIVE MARKET
  • 9.4 RESEARCH CENTERS
    • 9.4.1 NEED FOR ANALYZING LARGE VOLUMES OF DATA TO SUPPORT MARKET GROWTH
  • 9.5 OUTSOURCED LIFE SCIENCE ORGANIZATIONS
    • 9.5.1 RISING R&D OUTSOURCING BY LIFE SCIENCE COMPANIES TO DRIVE MARKET

10 LIFE SCIENCE ANALYTICS MARKET, BY REGION

  • 10.1 INTRODUCTION
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: MACROECONOMIC OUTLOOK
    • 10.2.2 US
      • 10.2.2.1 Established economy and increasing R&D expenditure to drive adoption of analytical solutions
    • 10.2.3 CANADA
      • 10.2.3.1 Rising need for data standardization in life sciences to fuel uptake
  • 10.3 EUROPE
    • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 10.3.2 GERMANY
      • 10.3.2.1 Growing R&D investments by pharmaceutical & biotechnology companies to drive market
    • 10.3.3 FRANCE
      • 10.3.3.1 Growing government support for adoption of AI & big data analytics to drive market
    • 10.3.4 UK
      • 10.3.4.1 Rising clinical trial activity to drive uptake of life science analytics solutions
    • 10.3.5 ITALY
      • 10.3.5.1 Growing number of drug approvals to drive uptake of analytics solutions
    • 10.3.6 SPAIN
      • 10.3.6.1 Surging government investments focusing on personalized medicine to drive growth
    • 10.3.7 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: MACROECONOMIC OUTLOOK
    • 10.4.2 JAPAN
      • 10.4.2.1 Growing government support for clinical R&D activities to drive adoption
    • 10.4.3 CHINA
      • 10.4.3.1 Growth in life science industry to support adoption of solutions
    • 10.4.4 INDIA
      • 10.4.4.1 Rising R&D expenditure and drug development to support market growth
    • 10.4.5 REST OF ASIA PACIFIC
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: MACROECONOMIC OUTLOOK
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to dominate life science analytics market in Latin America
    • 10.5.3 MEXICO
      • 10.5.3.1 Growing prominence of startups and rising R&D activity to propel market
    • 10.5.4 REST OF LATIN AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Rising investments, advancements, and developing healthcare infrastructure to drive market
    • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • 11.3 REVENUE ANALYSIS
  • 11.4 MARKET SHARE ANALYSIS
  • 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.5.1 STARS
    • 11.5.2 EMERGING LEADERS
    • 11.5.3 PERVASIVE PLAYERS
    • 11.5.4 PARTICIPANTS
    • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 11.5.5.1 Company footprint
      • 11.5.5.2 Type footprint
      • 11.5.5.3 Application footprint
      • 11.5.5.4 Component footprint
      • 11.5.5.5 End-user footprint
      • 11.5.5.6 Region footprint
  • 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 RESPONSIVE COMPANIES
    • 11.6.3 DYNAMIC COMPANIES
    • 11.6.4 STARTING BLOCKS
    • 11.6.5 COMPETITIVE BENCHMARKING
  • 11.7 BRAND/SOFTWARE COMPARATIVE ANALYSIS
  • 11.8 VALUATION & FINANCIAL METRICS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • 11.9.2 DEALS

12 COMPANY PROFILES

  • 12.1 KEY PLAYERS
    • 12.1.1 ORACLE
      • 12.1.1.1 Business overview
      • 12.1.1.2 Products & services offered
      • 12.1.1.3 Recent developments
        • 12.1.1.3.1 Deals
      • 12.1.1.4 MnM view
        • 12.1.1.4.1 Key strengths
        • 12.1.1.4.2 Strategic choices
        • 12.1.1.4.3 Weaknesses & competitive threats
    • 12.1.2 MERATIVE
      • 12.1.2.1 Business overview
      • 12.1.2.2 Products & services offered
        • 12.1.2.2.1 Deals
      • 12.1.2.3 MnM view
        • 12.1.2.3.1 Right to win
        • 12.1.2.3.2 Strategic choices
        • 12.1.2.3.3 Weaknesses & competitive threats
    • 12.1.3 SAS INSTITUTE INC.
      • 12.1.3.1 Business overview
      • 12.1.3.2 Products & services offered
      • 12.1.3.3 Recent developments
        • 12.1.3.3.1 Product launches & approvals
        • 12.1.3.3.2 Deals
      • 12.1.3.4 MnM view
        • 12.1.3.4.1 Right to win
        • 12.1.3.4.2 Strategic choices
        • 12.1.3.4.3 Weaknesses & competitive threats
    • 12.1.4 ACCENTURE
      • 12.1.4.1 Business overview
      • 12.1.4.2 Products offered
      • 12.1.4.3 Recent developments
        • 12.1.4.3.1 Deals
      • 12.1.4.4 MnM view
        • 12.1.4.4.1 Right to win
        • 12.1.4.4.2 Strategic choices
        • 12.1.4.4.3 Weaknesses & competitive threats
    • 12.1.5 IQVIA INC.
      • 12.1.5.1 Business overview
      • 12.1.5.2 Products & services offered
      • 12.1.5.3 Recent developments
        • 12.1.5.3.1 Product launches & approvals
        • 12.1.5.3.2 Deals
        • 12.1.5.3.3 Other developments
      • 12.1.5.4 MnM view
        • 12.1.5.4.1 Right to win
        • 12.1.5.4.2 Strategic choices
        • 12.1.5.4.3 Weaknesses & competitive threats
    • 12.1.6 COGNIZANT
      • 12.1.6.1 Business overview
      • 12.1.6.2 Products & services offered
      • 12.1.6.3 Recent developments
        • 12.1.6.3.1 Product launches & approvals
        • 12.1.6.3.2 Deals
    • 12.1.7 WIPRO
      • 12.1.7.1 Business overview
      • 12.1.7.2 Products & services offered
      • 12.1.7.3 Recent developments
        • 12.1.7.3.1 Deals
    • 12.1.8 VERADIGM LLC
      • 12.1.8.1 Business overview
      • 12.1.8.2 Products & services offered
      • 12.1.8.3 Recent developments
        • 12.1.8.3.1 Deals
    • 12.1.9 OPTUM, INC.
      • 12.1.9.1 Business overview
      • 12.1.9.2 Products & services offered
      • 12.1.9.3 Recent developments
        • 12.1.9.3.1 Deals
    • 12.1.10 MICROSOFT
      • 12.1.10.1 Business overview
      • 12.1.10.2 Products & services offered
      • 12.1.10.3 Recent developments
        • 12.1.10.3.1 Product & service launches & enhancements
        • 12.1.10.3.2 Deals
    • 12.1.11 MAXISIT
      • 12.1.11.1 Business overview
      • 12.1.11.2 Products & services offered
      • 12.1.11.3 Recent developments
        • 12.1.11.3.1 Product launches
        • 12.1.11.3.2 Deals
    • 12.1.12 EXLSERVICE HOLDINGS, INC.
      • 12.1.12.1 Business overview
      • 12.1.12.2 Products & services offered
      • 12.1.12.3 Recent developments
        • 12.1.12.3.1 Product launches
        • 12.1.12.3.2 Deals
    • 12.1.13 INOVALON
      • 12.1.13.1 Business overview
      • 12.1.13.2 Products & services offered
      • 12.1.13.3 Recent developments
        • 12.1.13.3.1 Product launches
        • 12.1.13.3.2 Deals
    • 12.1.14 CITIUSTECH INC.
      • 12.1.14.1 Business overview
      • 12.1.14.2 Products & services offered
      • 12.1.14.3 Recent developments
        • 12.1.14.3.1 Product launches
        • 12.1.14.3.2 Deals
        • 12.1.14.3.3 Expansions
    • 12.1.15 SAAMA
      • 12.1.15.1 Business overview
      • 12.1.15.2 Products & services offered
      • 12.1.15.3 Recent developments
        • 12.1.15.3.1 Deals
    • 12.1.16 AXTRIA
      • 12.1.16.1 Business overview
      • 12.1.16.2 Products & services offered
      • 12.1.16.3 Recent developments
        • 12.1.16.3.1 Product launches
        • 12.1.16.3.2 Deals
        • 12.1.16.3.3 Expansions
    • 12.1.17 CLARIVATE
      • 12.1.17.1 Business overview
      • 12.1.17.2 Products & services offered
      • 12.1.17.3 Recent developments
        • 12.1.17.3.1 Product enhancements
        • 12.1.17.3.2 Deals
    • 12.1.18 THOUGHTSPHERE
      • 12.1.18.1 Business overview
      • 12.1.18.2 Products & services offered
      • 12.1.18.3 Recent developments
        • 12.1.18.3.1 Deals
    • 12.1.19 THOUGHTSPOT INC.
      • 12.1.19.1 Business overview
      • 12.1.19.2 Products & services offered
      • 12.1.19.3 Recent developments
        • 12.1.19.3.1 Deals
        • 12.1.19.3.2 Expansions
    • 12.1.20 SALESFORCE, INC.
      • 12.1.20.1 Business overview
      • 12.1.20.2 Products & services offered
      • 12.1.20.3 Recent developments
        • 12.1.20.3.1 Deals
  • 12.2 OTHER PLAYERS
    • 12.2.1 GOOGLE LLC
    • 12.2.2 AMAZON WEB SERVICES, INC.
    • 12.2.3 VEEVA SYSTEMS
    • 12.2.4 ELSEVIER
    • 12.2.5 KOMODO HEALTH, INC.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • TABLE 2 LIFE SCIENCE ANALYTICS MARKET: RISK ASSESSMENT
  • TABLE 3 PHARMACEUTICAL COMPANIES IMPACTED BY CYBERINCIDENTS, 2024
  • TABLE 4 LIFE SCIENCE ANALYTICS MARKET: ROLE IN ECOSYSTEM
  • TABLE 5 LIFE SCIENCE ANALYTICS MARKET: PORTER'S FIVE FORCES
  • TABLE 6 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
  • TABLE 7 KEY BUYING CRITERIA FOR END USERS
  • TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 AVERAGE SELLING PRICE OF LIFE SCIENCE ANALYTICS SOLUTIONS, BY APPLICATION
  • TABLE 14 AVERAGE SELLING PRICE OF ANALYTICS SOLUTIONS, BY REGION
  • TABLE 15 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • TABLE 16 LIST OF PATENTS/PATENT APPLICATIONS
  • TABLE 17 UNMET NEEDS IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 18 END-USER EXPECTATIONS IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 19 MAJOR INVESTMENTS IN AI IN LIFE SCIENCE ANALYTICS MARKET
  • TABLE 20 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 21 DESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 22 PREDICTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 23 PRESCRIPTIVE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 24 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 25 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 26 LIFE SCIENCE ANALYTICS SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 27 MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 28 MANAGED SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 29 ANALYTICAL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 30 CONSULTING SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 31 PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 32 PROFESSIONAL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 33 TRAINING & IMPLEMENTATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 34 MAINTENANCE & SUPPORT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 35 OTHER PROFESSIONAL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 36 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 37 LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 38 ON-PREMISE SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 39 CLOUD-BASED SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 40 SAAS-BASED SOLUTIONS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 41 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 42 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE R&D SOLUTIONS
  • TABLE 43 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 44 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 45 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE CLINICAL TRIAL SOLUTIONS
  • TABLE 46 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 47 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 48 LABORATORY SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 49 PATIENT RECRUITMENT SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 50 SITE IDENTIFICATION SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 51 OTHER CLINICAL TRIAL SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 52 LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 53 PHASE I CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 54 PHASE II CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 55 PHASE III CLINICAL TRIAL ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 56 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PRECLINICAL SOLUTIONS
  • TABLE 57 LIFE SCIENCE ANALYTICS MARKET FOR PRECLINICAL & DRUG DISCOVERY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 58 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 59 LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 60 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SALES & MARKETING SOLUTIONS
  • TABLE 61 LIFE SCIENCE ANALYTICS MARKET FOR SALES & MARKETING SUPPORT, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 62 LIFE SCIENCE ANALYTICS MARKET FOR MARKET ACCESS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 63 LIFE SCIENCE ANALYTICS MARKET FOR RWE & VALUE EVIDENCE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 64 LIFE SCIENCE ANALYTICS MARKET FOR ENGAGEMENT SERVICES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 65 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE REGULATORY COMPLIANCE SOLUTIONS
  • TABLE 66 LIFE SCIENCE ANALYTICS MARKET FOR REGULATORY COMPLIANCE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 67 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE SUPPLY CHAIN OPTIMIZATION SOLUTIONS
  • TABLE 68 LIFE SCIENCE ANALYTICS MARKET FOR MANUFACTURING & SUPPLY CHAIN OPTIMIZATION, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 69 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 70 LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 71 LIFE SCIENCE ANALYTICS MARKET: COMMERCIALLY AVAILABLE PHARMACOVIGILANCE SOLUTIONS
  • TABLE 72 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACOVIGILANCE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 73 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE SAFETY, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 74 LIFE SCIENCE ANALYTICS MARKET FOR DIAGNOSTIC VIGILANCE, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 75 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 76 LIFE SCIENCE ANALYTICS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 77 LIFE SCIENCE ANALYTICS MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 78 LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH CENTERS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 79 LIFE SCIENCE ANALYTICS MARKET FOR OUTSOURCED LIFE SCIENCE ORGANIZATIONS, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 80 LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 81 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 82 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 83 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 85 NORTH AMERICA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 86 NORTH AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 87 NORTH AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 88 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 89 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 90 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 91 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 93 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 94 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 95 US: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 96 US: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 97 US: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 98 US: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 99 US: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 100 US: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 101 US: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 102 US: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 103 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 104 US: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 105 US: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 106 US: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 107 US: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 108 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 109 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 110 CANADA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 111 CANADA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 112 CANADA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 113 CANADA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 114 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 115 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 116 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 117 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 118 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 119 CANADA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 120 CANADA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 121 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 122 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 123 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 124 EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 125 EUROPE: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 126 EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 127 EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 128 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 129 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 130 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 131 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 132 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 133 EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 134 EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 135 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 136 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 137 GERMANY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 138 GERMANY: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 139 GERMANY: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 140 GERMANY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 141 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 142 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 143 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 144 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 145 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 146 GERMANY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 147 GERMANY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 148 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 149 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 150 FRANCE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 151 FRANCE: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 152 FRANCE: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 153 FRANCE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 154 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 155 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 156 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 157 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 158 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 159 FRANCE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 160 FRANCE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 161 UK: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 162 UK: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 163 UK: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 164 UK: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 165 UK: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 166 UK: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 167 UK: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 168 UK: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 169 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 170 UK: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 171 UK: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 172 UK: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 173 UK: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 174 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 175 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 176 ITALY: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 177 ITALY: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 178 ITALY: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 179 ITALY: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 180 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 181 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 182 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 183 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 184 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 185 ITALY: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 186 ITALY: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 187 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 188 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 189 SPAIN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 190 SPAIN: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 191 SPAIN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 192 SPAIN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 193 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 194 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 195 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 196 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 197 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 198 SPAIN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 199 SPAIN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 200 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 201 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 202 REST OF EUROPE: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 203 REST OF EUROPE: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 204 REST OF EUROPE: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 205 REST OF EUROPE: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 206 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 207 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 208 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 209 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 210 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 211 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 212 REST OF EUROPE: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 213 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 214 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 215 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 216 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 218 ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 219 ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 220 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 221 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 222 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 223 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 225 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 226 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 227 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 228 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 229 JAPAN: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 230 JAPAN: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 231 JAPAN: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 232 JAPAN: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 233 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 234 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 235 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 236 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 237 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 238 JAPAN: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 239 JAPAN: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 240 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 241 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 242 CHINA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 243 CHINA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 244 CHINA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 245 CHINA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 246 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 247 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 248 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 249 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 250 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 251 CHINA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 252 CHINA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 253 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 254 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 255 INDIA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 256 INDIA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 257 INDIA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 258 INDIA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 259 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 260 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 261 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 262 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 263 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 264 INDIA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 265 INDIA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 266 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 267 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 268 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 269 REST OF ASIA PACIFIC: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 270 REST OF ASIA PACIFIC: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 271 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 272 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 273 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 274 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 275 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 276 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 277 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 278 REST OF ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 279 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • TABLE 280 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 281 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 282 LATIN AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 283 LATIN AMERICA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 284 LATIN AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 285 LATIN AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 286 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 287 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 288 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 289 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 290 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 291 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 292 LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 293 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 294 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 295 BRAZIL: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 296 BRAZIL: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 297 BRAZIL: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 298 BRAZIL: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 299 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 300 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 301 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 302 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 303 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 304 BRAZIL: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 305 BRAZIL: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 306 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 307 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 308 MEXICO: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 309 MEXICO: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 310 MEXICO: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 311 MEXICO: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 312 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 313 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 314 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 315 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 316 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 317 MEXICO: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 318 MEXICO: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 319 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 320 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 321 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 322 REST OF LATIN AMERICA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 323 REST OF LATIN AMERICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 324 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 325 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 326 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 327 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 328 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 329 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 330 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 331 REST OF LATIN AMERICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 332 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • TABLE 333 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 334 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 335 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 336 MIDDLE EAST & AFRICA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 337 MIDDLE EAST & AFRICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 338 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 339 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 340 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 341 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 342 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 343 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 344 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 345 MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 346 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 347 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 348 GCC COUNTRIES: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 349 GCC COUNTRIES: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 350 GCC COUNTRIES: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 351 GCC COUNTRIES: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 352 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 353 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 354 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 356 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 357 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 358 GCC COUNTRIES: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 359 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 360 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2022-2029 (USD MILLION)
  • TABLE 361 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 362 REST OF MIDDLE EAST & AFRICA: MANAGED SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 363 REST OF MIDDLE EAST & AFRICA: PROFESSIONAL SERVICES MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 364 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS SOFTWARE MARKET, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 365 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
  • TABLE 366 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 367 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 368 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR CLINICAL TRIALS, BY PHASE, 2022-2029 (USD MILLION)
  • TABLE 369 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR COMMERCIAL ANALYTICS, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 370 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET FOR SAFETY, BY TYPE, 2022-2029 (USD MILLION)
  • TABLE 371 REST OF MIDDLE EAST & AFRICA: LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • TABLE 372 LIFE SCIENCE ANALYTICS MARKET: DEGREE OF COMPETITION
  • TABLE 373 LIFE SCIENCE ANALYTICS MARKET: TYPE FOOTPRINT (25 COMPANIES)
  • TABLE 374 LIFE SCIENCE ANALYTICS MARKET: APPLICATION FOOTPRINT (25 COMPANIES)
  • TABLE 375 LIFE SCIENCE ANALYTICS MARKET: COMPONENT FOOTPRINT (25 COMPANIES)
  • TABLE 376 LIFE SCIENCE ANALYTICS MARKET: END-USER FOOTPRINT (25 COMPANIES)
  • TABLE 377 LIFE SCIENCE ANALYTICS MARKET: REGION FOOTPRINT (25 COMPANIES)
  • TABLE 378 LIFE SCIENCE ANALYTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
  • TABLE 379 LIFE SCIENCE ANALYTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
  • TABLE 380 LIFE SCIENCE ANALYTICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 381 LIFE SCIENCE ANALYTICS MARKET: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 382 ORACLE: COMPANY OVERVIEW
  • TABLE 383 ORACLE: PRODUCTS & SERVICES OFFERED
  • TABLE 384 ORACLE: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 385 MERATIVE: COMPANY OVERVIEW
  • TABLE 386 MERATIVE: PRODUCTS & SERVICES OFFERED
  • TABLE 387 MERATIVE: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 388 SAS INSTITUTE: COMPANY OVERVIEW
  • TABLE 389 SAS INSTITUTE: PRODUCTS & SERVICES OFFERED
  • TABLE 390 SAS INSTITUTE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 391 SAS INSTITUTE: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 392 ACCENTURE: COMPANY OVERVIEW
  • TABLE 393 ACCENTURE: PRODUCTS OFFERED
  • TABLE 394 ACCENTURE: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 395 IQVIA: COMPANY OVERVIEW
  • TABLE 396 IQVIA: PRODUCTS & SERVICES OFFERED
  • TABLE 397 IQVIA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 398 IQVIA: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 399 IQVIA: OTHER DEVELOPMENTS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 400 COGNIZANT: COMPANY OVERVIEW
  • TABLE 401 COGNIZANT: PRODUCTS & SERVICES OFFERED
  • TABLE 402 COGNIZANT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 403 COGNIZANT: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 404 WIPRO: COMPANY OVERVIEW
  • TABLE 405 WIPRO: PRODUCTS & SERVICES OFFERED
  • TABLE 406 WIPRO: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 407 VERADIGM: COMPANY OVERVIEW
  • TABLE 408 VERADIGM: PRODUCTS & SERVICES OFFERED
  • TABLE 409 VERADIGM: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 410 OPTUM: COMPANY OVERVIEW
  • TABLE 411 OPTUM: PRODUCTS & SERVICES OFFERED
  • TABLE 412 OPTUM: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 413 MICROSOFT: COMPANY OVERVIEW
  • TABLE 414 MICROSOFT: PRODUCTS & SERVICES OFFERED
  • TABLE 415 MICROSOFT: PRODUCT & SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 416 MICROSOFT: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 417 MAXISIT: COMPANY OVERVIEW
  • TABLE 418 MAXISIT: PRODUCTS & SERVICES OFFERED
  • TABLE 419 MAXISIT: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 420 MAXISIT: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 421 EXLSERVICE HOLDINGS: COMPANY OVERVIEW
  • TABLE 422 EXLSERVICE HOLDINGS: PRODUCTS & SERVICES OFFERED
  • TABLE 423 EXLSERVICE HOLDINGS: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 424 EXLSERVICE HOLDINGS: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 425 INOVALON: COMPANY OVERVIEW
  • TABLE 426 INOVALON: PRODUCTS & SERVICES OFFERED
  • TABLE 427 INOVALON: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 428 INOVALON: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 429 CITIUSTECH: COMPANY OVERVIEW
  • TABLE 430 CITIUSTECH: PRODUCTS & SERVICES OFFERED
  • TABLE 431 CITIUSTECH: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 432 CITIUSTECH: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 433 CITIUSTECH: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 434 SAAMA: COMPANY OVERVIEW
  • TABLE 435 SAAMA: PRODUCTS & SERVICES OFFERED
  • TABLE 436 SAAMA: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 437 AXTRIA: COMPANY OVERVIEW
  • TABLE 438 AXTRIA: PRODUCTS & SERVICES OFFERED
  • TABLE 439 AXTRIA: PRODUCT LAUNCHES, JANUARY 2021-SEPTEMBER 2024
  • TABLE 440 AXTRIA: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 441 AXTRIA: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 442 CLARIVATE: COMPANY OVERVIEW
  • TABLE 443 CLARIVATE: PRODUCTS & SERVICES OFFERED
  • TABLE 444 CLARIVATE: PRODUCT ENHANCEMENTS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 445 CLARIVATE: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 446 THOUGHTSPHERE: COMPANY OVERVIEW
  • TABLE 447 THOUGHTSPHERE.: PRODUCTS & SERVICES OFFERED
  • TABLE 448 THOUGHTSPHERE.: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 449 THOUGHTSPOT: COMPANY OVERVIEW
  • TABLE 450 THOUGHTSPOT: PRODUCTS & SERVICES OFFERED
  • TABLE 451 THOUGHTSPOT: DEALS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 452 THOUGHTSPOT: EXPANSIONS, JANUARY 2021-SEPTEMBER 2024
  • TABLE 453 SALESFORCE: COMPANY OVERVIEW
  • TABLE 454 SALESFORCE: PRODUCTS & SERVICES OFFERED
  • TABLE 455 SALESFORCE: DEALS, JANUARY 2021-SEPTEMBER 2024

List of Figures

  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 PRIMARY SOURCES
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
  • FIGURE 5 LIFE SCIENCE ANALYTICS MARKET: REVENUE SHARE ANALYSIS ILLUSTRATION
  • FIGURE 6 BOTTOM-UP APPROACH: END-USER SPENDING ON LIFE SCIENCE ANALYTICS
  • FIGURE 7 LIFE SCIENCE ANALYTICS MARKET: CAGR PROJECTION FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2024-2029)
  • FIGURE 8 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
  • FIGURE 9 TOP-DOWN APPROACH
  • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • FIGURE 11 LIFE SCIENCE ANALYTICS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 LIFE SCIENCE ANALYTICS MARKET, BY COMPONENT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 LIFE SCIENCE ANALYTICS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 14 LIFE SCIENCE ANALYTICS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 15 LIFE SCIENCE ANALYTICS MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 16 RISING TECHNOLOGICAL ADVANCEMENTS AND GROWING ADOPTION OF ANALYTICS SOLUTIONS FOR CLINICAL TRIALS TO DRIVE MARKET
  • FIGURE 17 NORTH AMERICA TO DOMINATE LABORATORY INFORMATICS MARKET DURING FORECAST PERIOD
  • FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN NORTH AMERICA ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 19 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
  • FIGURE 21 LIFE SCIENCE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 22 HEALTH EXPENDITURE AS SHARE OF GDP, 2022 (OR NEAREST YEAR)
  • FIGURE 23 LIFE SCIENCE ANALYTICS MARKET ECOSYSTEM
  • FIGURE 24 LIFE SCIENCE ANALYTICS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 LIFE SCIENCE ANALYTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
  • FIGURE 27 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 28 REVENUE SHIFT IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 29 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR "LIFE SCIENCE ANALYTICS" PATENTS, JANUARY 2011-SEPTEMBER 2024
  • FIGURE 30 MAJOR PATENTS FOR LIFE SCIENCE ANALYTICS (JANUARY 2011- SEPTEMBER 2024)
  • FIGURE 31 FUNDING OF PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 32 MARKET POTENTIAL OF AI/GENERATIVE AI, BY INDUSTRY
  • FIGURE 33 IMPACT OF GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 34 NORTH AMERICA: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: LIFE SCIENCE ANALYTICS MARKET SNAPSHOT
  • FIGURE 36 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET
  • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN LIFE SCIENCE ANALYTICS MARKET (2019-2023)
  • FIGURE 38 LIFE SCIENCE ANALYTICS MARKET: MARKET SHARE ANALYSIS (2023)
  • FIGURE 39 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 40 LIFE SCIENCE ANALYTICS MARKET: COMPANY FOOTPRINT (25 COMPANIES)
  • FIGURE 41 LIFE SCIENCE ANALYTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 42 EV/EBITDA OF KEY VENDORS
  • FIGURE 43 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF LIFE SCIENCE ANALYTICS VENDORS
  • FIGURE 44 ORACLE: COMPANY SNAPSHOT (2023)
  • FIGURE 45 ACCENTURE: COMPANY SNAPSHOT (2023)
  • FIGURE 46 IQVIA: COMPANY SNAPSHOT (2023)
  • FIGURE 47 COGNIZANT: COMPANY SNAPSHOT (2023)
  • FIGURE 48 WIPRO: COMPANY SNAPSHOT (2023)
  • FIGURE 49 VERADIGM: COMPANY SNAPSHOT (2023)
  • FIGURE 50 UNITED HEALTH GROUP: COMPANY SNAPSHOT (2023)
  • FIGURE 51 MICROSOFT: COMPANY SNAPSHOT (2023)
  • FIGURE 52 EXLSERVICE HOLDINGS: COMPANY SNAPSHOT (2023)
  • FIGURE 53 CLARIVATE: COMPANY SNAPSHOT (2023)
  • FIGURE 54 SALESFORCE: COMPANY SNAPSHOT (2023)